Want to join the conversation?
$BMY 2Q15 Call: Over next five years, expects growth to come primarily from Opdivo and Eliquis with contribution from the rest of existing portfolio of medicines. Announced today that European Commission validated two Opdivo applications; one for non-squamous cell lung cancer and two in combination with Yervoy for Metastatic Melanoma.
$AAL is giving pay hikes to its employees but investors are sulking.
$APC stock tumbled more than 5.6% after last week's fatal home explosion in Firestone, Colorado prompted the company to close more than 3,000 wells for weeks.
Unicorn Frappuccino. The latest hit from $SBUX. Can't wait to see how this will affect its results.
At what point should $AMZN consider a stock split? $1000 per share seems pretty high.